Partner Content Partner Content 4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED Drug Discovery Conference
News Novo Nordisk claims first GLP-1 approval in MASH Under pressure from rivals in the GLP-1 space, Novo Nordisk has been given a leg-up with a first-in-class approval for Wegovy in liver disease MASH.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
